ELLISON INSTITUTE OF TECHNOLOGY
LIVE

Serial Number

98123216

Owner

ELLISON INSTITUTE, LLC

Attorney

Aaron D. Hendelman

Filing Date

Aug 8, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ELLISON INSTITUTE OF TECHNOLOGY Trademark

Serial Number: 98123216

ELLISON INSTITUTE OF TECHNOLOGY is a trademark filed by ELLISON INSTITUTE, LLC on August 8, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

ELLISON INSTITUTE, LLC (12 trademarks)

LOS ANGELES, CA 90064

Entity Type: 16

ELLISON INSTITUTE OF TECHNOLOGY, OXFORD LIMITED (8 trademarks)

WINCHESTER HOUSE, HEATLEY ROAD, THE OXFORD SCIENCE PARK
OXFORD OX4 4GE , GB

Entity Type: 11

Trademark Details

Filing Date

August 8, 2023

Registration Date

Not Registered

Goods & Services

Compilation of statistics; market research; arranging, conducting and hosting of exhibition, conferences and seminars for business purposes; business management and consulting services, namely, managing logistics, reverse logistics, supply chain services, supply chain visibility and synchronization, pricing forecasting, supply and demand forecasting and product distribution processes for others; economic forecasting services; market forecasting; commercial assistance relating to system implementation and system integration; business consulting services relating to the integration of the areas of business process technology, organizational learning, change management, and operational sustainability; collection and analysis of quality metric data in the fields of health, digital health, health data, healthcare access, disease prevention, medical and scientific research, health security, biomedical research, biotechnology, bioinformatics, bioengineering, data analytics, data science, food security, housing, and climate science for business purposes; business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; business consulting and management in the field of clinical trials, namely, providing information management services

Healthcare services, namely, treatment and diagnosis of cancer; healthcare medical diagnostic testing, monitoring and reporting services for research purposes; consulting services in the fields of diagnostic medical testing; health care services for treating cancer

Downloadable mobile applications using artificial intelligence for use in creating, developing, sharing and analyzing data in the fields of digital health, health data, healthcare access, disease prevention, education, medical and scientific research, health security, biomedical research, biotechnology, bioinformatics, bioengineering, data analytics, data science, food security, housing, and climate science

Development of biomedical technologies and products for others in the nature of biomedical education technologies; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; research and development of vaccines and medicines; research, development, engineering and testing services in the fields of pharmaceuticals and vaccines; biotechnology research services, and research and development of new products in the fields of gene therapeutics; design of genetic research tools and systems for others; compiling data for research purposes in the fields of medical science; scientific research and development, namely, development of new scientific computational technologies to predict positive and negative regulators of gene network function; developing new technology for others in the field of computational genomics; genome sequencing services for scientific and research purposes; providing genetic sequencing and consulting services for clinical research purposes; vaccine research and development; application service provider, namely, hosting, managing, developing, analyzing, and maintaining applications, software, and web sites, of others in the fields of cancer treatment, cancer diagnosis, digital health, health data, healthcare access, disease prevention, education, medical and scientific research, health security, biomedical research, biotechnology, bioinformatics, bioengineering, data analytics, data science, food security, housing, and climate science; research in the field of artificial intelligence; providing temporary use of nondownloadable software using artificial intelligence for use in creating, developing, sharing and analyzing data in the fields of digital health, health data, healthcare access, disease prevention, education, medical and scientific research, health security, biomedical research, biotechnology, bioinformatics, bioengineering, data analytics, data science, food security, housing, and climate science; consulting services for others in the field of design, planning, and implementation project management of scientific research and clinical trials; genetic testing for medical research purposes; providing genetic sequencing and consulting services for medical research purposes

Venture capital services, namely, investment funding of companies and organizations; financial forecasting services

Educational services, namely, providing courses of instruction at the high school, undergraduate and graduate level education in the fields of cancer prevention, cancer screening, cancer, diagnosis, cancer treatment, digital health, health data, healthcare access, disease prevention, education, medical and scientific research, health security, biomedical research, biotechnology, bioinformatics, bioengineering, data analytics, data science, food security, housing, and climate science; providing information in the fields of education via a website; providing a website featuring blogs and non-downloadable publications in the nature of articles in the fields of digital health, health data, healthcare access, disease prevention, education, medical and scientific research, health security, biomedical research, biotechnology, bioinformatics, bioengineering, data analytics, data science, food security, housing, and climate science; publication of educational and training guides; production of films for educational purposes; organization of educational competitions and awards to demonstrate excellence in the fields of digital health, disease prevention, education, medical and scientific research, health security, biomedical research, biotechnology, bioinformatics, bioengineering, data analytics, data science, food security, housing, and climate science

Legal research and consultancy in the field of public policy

Filing History

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jun 24, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jun 24, 2026 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 13, 2026 GNFN
FINAL REFUSAL E-MAILED
Apr 13, 2026 GNFR
FINAL REFUSAL WRITTEN
Apr 13, 2026 CNFR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 9, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 9, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 9, 2025 REAP
DIVISIONAL PROCESSING COMPLETE
Aug 20, 2025 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 20, 2025 AITU
RESPONSE TO ITU OFFICE ACTION ENTERED
Aug 11, 2025 IROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 11, 2025 TROA
ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Aug 11, 2025 INCD
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 11, 2025 AITU
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
May 14, 2025 ASGN
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 9, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 9, 2024 CRFA
ASSIGNED TO LIE
Oct 9, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 21, 2024 TROA
NOTICE OF REVIVAL - E-MAILED
Jun 21, 2024 NREV
PETITION TO REVIVE-GRANTED
Jun 21, 2024 PETG
TEAS PETITION TO REVIVE RECEIVED
Jun 21, 2024 PROA
DIVISIONAL REQUEST RECEIVED
Jun 20, 2024 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Jun 20, 2024 ERTD
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Mar 18, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Mar 18, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 20, 2023 GNRN
NON-FINAL ACTION E-MAILED
Dec 20, 2023 GNRT
NON-FINAL ACTION WRITTEN
Dec 20, 2023 CNRT
ASSIGNED TO EXAMINER
Dec 18, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 7, 2023 NWOS
NEW APPLICATION ENTERED
Aug 11, 2023 NWAP